Osaic Holdings
NVS icon

Osaic Holdings’s Novartis NVS Stock Holding History

Osaic Holdings’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1M Buy
172,539
+3,527
+2% +$529K 0.03% 555
2026
Q1 		$25.8M Buy
169,012
+2,288
+1% +$351K 0.04% 484
2025
Q4 		$23M Sell
166,724
-65,183
-28% -$8.54M 0.03% 516
2025
Q3 		$29.5M Buy
231,907
+50,430
+28% +$6.15M 0.04% 467
2025
Q2 		$21.4M Buy
181,477
+79,507
+78% +$8.96M 0.04% 476
2025
Q1 		$11.4M Sell
101,970
-19,103
-16% -$2.03M 0.03% 629
2024
Q4 		$11.8M Buy
121,073
+10,559
+10% +$1.13M 0.03% 593
2024
Q3 		$12.7M Buy
110,514
+3,083
+3% +$350K 0.03% 578
2024
Q2 		$11.4M Buy
107,431
+16,095
+18% +$1.62M 0.03% 585
2024
Q1 		$8.84M Sell
91,336
-102,478
-53% -$10.5M 0.02% 747
2023
Q4 		$19.6M Sell
193,814
-53,655
-22% -$5.18M 0.03% 489
2023
Q3 		$25.2M Buy
247,469
+91,036
+58% +$9.24M 0.04% 460
2023
Q2 		$15.8M Buy
156,433
+17,477
+13% +$1.75M 0.03% 548
2023
Q1 		$12.8M Buy
138,956
+3,167
+2% +$277K 0.02% 637
2022
Q4 		$12.3M Sell
135,789
-3,430
-2% -$289K 0.02% 635
2022
Q3 		$10.6M Buy
139,219
+476
+0.3% +$39.5K 0.02% 626
2022
Q2 		$11.7M Buy
138,743
+8,610
+7% +$755K 0.03% 585
2022
Q1 		$11.9M Buy
130,133
+5,341
+4% +$462K 0.02% 656
2021
Q4 		$10.9M Buy
124,792
+6,536
+6% +$543K 0.02% 698
2021
Q3 		$9.67M Sell
118,256
-4,017
-3% -$361K 0.02% 684
2021
Q2 		$11.2M Buy
122,273
+2,228
+2% +$198K 0.02% 604
2021
Q1 		$10.3M Sell
120,045
-11,401
-9% -$1.02M 0.02% 583
2020
Q4 		$12.4M Buy
131,446
+1,822
+1% +$159K 0.03% 455
2020
Q3 		$11.3M Sell
129,624
-2,116
-2% -$183K 0.03% 428
2020
Q2 		$11.5M Sell
131,740
-97,566
-43% -$8.42M 0.04% 396
2020
Q1 		$11.7M Buy
+229,306
New +$20.5M 0.05% 333

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Osaic Holdings's NVS Position: Q2 2026 in Review

Osaic Holdings increased its Novartis (NVS) stake by 2.1% in Q2 2026, buying an estimated $529K and bringing the position to 172,539 shares worth $27.1M. The position accounts for 0.03% of the portfolio, ranked #555.

Osaic Holdings first reported a position in NVS in Q1 2020 and has held it in 26 quarters since. The position peaked at $29.5M in Q3 2025. 1,623 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Osaic Holdings held 172,539 shares of Novartis worth $27.1M as of Q2 2026.
  • Osaic Holdings bought 3,527 Novartis shares in Q2 2026, an estimated $529K.
  • Novartis made up 0.03% of Osaic Holdings's portfolio in Q2 2026, its #555 holding.
  • Osaic Holdings first reported a position in Novartis in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Novartis position peaked at $29.5M in Q3 2025.
  • 1,623 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.